BioTherapies Inc

Innovative BioTherapies Inc. (IBT), founded in 2003 by Dr. H. David Humes, is a for-profit company based in Ann Arbor, Michigan, dedicated to commercializing technology developed in the University of Michigan's academic laboratory. The company focuses on creating bioartificial organ-based devices using adult progenitor cells, biomaterials, and MEMs technology, with its research and development efforts primarily supported by federal grants and contracts.

IBT aims to revolutionize the field of medicine by advancing innovative solutions in biotechnology, particularly in the realm of organ replacement and support. Through its commitment to research and development, the company is positioned at the forefront of bioengineering and regenerative medicine.

Generated from the website